Navigation Links
Sysmex and Siemens Renew Global Partnership for Hemostasis Solutions and Services
Date:7/19/2012

LOS ANGELES, July 19, 2012 /PRNewswire/ -- Sysmex Corporation (HQ: Kobe, Japan; President and CEO: Hisashi Ietsugu) and Siemens Healthcare Diagnostics (HQ: NY, USA; CEO: Michael Reitermann) have announced the signing of a five-year global supply, distributorship, sales and service contract extension under which clinical laboratory customers around the world can retain access to the largest portfolio of innovative hemostasis instruments and reagents through 2018. The companies, which began partnering in 1995, also agreed to continue joint product development activities, ensuring customer access to new hemostasis technology. The signing occurred during the 2012 AACC and ASCLS Annual Meetings and Clinical Lab Expo in Los Angeles, California.

The large assortment of hemostasis products covered in this latest agreement is used by clinical laboratories to test for blood disorders in patients and to monitor patients on blood-thinning medication. To date, Sysmex and Siemens have released to market a variety of advanced solutions, including the recently launched Sysmex CS-5100*(1), the top-end model in Sysmex's CS hemostasis analyzer series, the Sysmex® CA-600 Systems*(1), a new line of compact, fully automated hemostasis analyzers, as well as several new Siemens INNOVANCE™ reagents.

"We are pleased to extend our longstanding relationship with Siemens Healthcare Diagnostics," said Hisashi Ietsugu, President and CEO of Sysmex Corporation. "Our partnership in the field of hemostasis combines the strength of two leading diagnostics companies whose joint expertise offers best-in-class solutions to the laboratory. We remain committed to further expand our offerings with enhanced clinical utility and workflow efficiency."

"Our shared goal to deliver high quality products and services that address our customers' needs is a key reason for the success of our 17-year relationship," said Michael Reitermann, CEO, Siemens Healthcare Diagnostics. "Sysmex and Siemens remains a reliable partnership for customers worldwide amidst an evolving hemostasis market. Together, we will continue offering customers the broad portfolio of hemostasis solutions they have come to expect from us and we will also focus on delivering next-generation technologies going forward."

Disclaimer
1) The products/features mentioned herein are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed.

About Sysmex Corporation
Sysmex Corporation is a world leader in clinical laboratory systemization and solutions, including laboratory diagnostics, laboratory automation and clinical information systems. Serving customers for more than 40 years, Sysmex focuses on technological leadership in diagnostic science and information tools that make a difference in the health of people worldwide. The company is also exploring emerging opportunities in the life science field. Its R & D efforts focus on the development of high-value-added testing and diagnostic technologies that are innovative, original and optimize individual health. Sysmex also seeks to leverage its state-of-the-art technologies for gene and protein analysis. The company, headquartered in Kobe, Japan, has subsidiaries in North America, Latin America, Europe, China and Asia Pacific and employs more than 5,000 employees worldwide.  Sysmex Corporation is listed in the top tier of the Tokyo Stock Exchange. For more information about Sysmex Corporation and its affiliate companies, please visit http://www.sysmex.co.jp/en/.

About Siemens Healthcare Sector
The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 51,000 employees worldwide and operates around the world. In fiscal year 2011 (to September 30), the Sector posted revenue of 12.5 billion euros and profit of around 1.3 billion euros. For further information please visit: www.siemens.com/healthcare.


'/>"/>
SOURCE Sysmex Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
2. At SIIM 2012 Siemens Healthcare Demonstrates Departmental IT Solutions That Help Administrators Increase Access while Managing Costs
3. FDA Clears New Siemens SOMATOM Perspective CT Scanner
4. Siemens SOMATOM Definition Edge Single-Source CT Cleared for Sale in U.S.
5. Frost & Sullivan Recognizes Siemens Healthcares CT Imaging Solution for the Value it Offers Both Service Providers and Patients
6. Siemens Unveils New Solutions and Latest Innovations at AACC 2012
7. Siemens Launches Next Generation Automation Solution Aptio at AACC 2012
8. Cardinal Health, Detroit Medical Center, Henry Ford Health System Announce Unique Collaboration To Promote Urban Renewal
9. Misonix And SIAD Healthcare Renew Distribution Agreement For Italy
10. Top buyers including Atico, Coles Group Asia, Kmart, Staples, Office Depot and Target Australia pre-registered to attend Global Sources spring China Sourcing Fairs
11. ConvaTec Donates $10,000 To AAWC Global Volunteers Program Through SAWC Walk For Wellness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... 2016 The primary goal of this research ... on the usage of liquid biopsy. Key information the ... - Timeframe of liquid biopsy adoption amidst future users ... organization type - Sample inflow to conduct liquid biopsy ... serum, and so on. - Correlation analysis of sample ...
(Date:2/11/2016)... 11, 2016 PRO-DEX, INC. (NasdaqCM: PDEX) today announced ... 31, 2015. The Company also filed its Quarterly Report on ... with the Securities and Exchange Commission today. ... --> --> Net sales ... million, or 95%, to $5.4 million from $2.8 million for ...
(Date:2/11/2016)... -- Kindred Biosciences, Inc. (NASDAQ: KIN ), a biopharmaceutical ... pets, today announced the submission to FDA of the ... (NADA) for Zimeta™ (dipyrone injection, KIND-012).  Positive topline results ... the control of pyrexia (fever) in horses were recently ... --> The Chemistry, Manufacturing, and Controls technical ...
Breaking Medicine Technology:
(Date:2/13/2016)... ... February 13, 2016 , ... The producers of Enterprises TV ... , The increasingly modern world of instantaneous consumption proves very convenient for businesses. ... such as oil and coal, which pollutes our air, water, and soil. It can ...
(Date:2/13/2016)... , ... February 13, 2016 , ... ... Outlook’s top Clinical Data Management Solution Providers list for its expertise in eClinical ... and domain expertise to serve the technology needs of global clients. DDi provides ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... exclusively to funding innovative lymphoma research and serving the lymphoma community through a ... 250 members of South Florida’s philanthropic community at its 10th anniversary Fashion Luncheon ...
(Date:2/12/2016)... ... ... Coco Libre, the maker of coconut water beverages with a purpose, is ... Coco Libre will offer musicians and celebrities the company’s signature Organic Coconut Water, a ... suite, held this year at the W Hollywood Hotel, has become a pre-show “must” ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... Fisher House ... Vegas Mayor John J. Lee, Nevada Military Support Alliance president Scott Bensing, and Peggy ... at the VA Southern Nevada Healthcare System. This will be the first Fisher ...
Breaking Medicine News(10 mins):